PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23142694-13	2013	FK506, which interacts with ALK2, increased ET-1 levels and ID1 levels, and this was blocked by ALK2 knockdown.	Tacrolimus	0-5	activin A receptor type 1	Homo sapiens	28-32	
23142694-13	2013	FK506, which interacts with ALK2, increased ET-1 levels and ID1 levels, and this was blocked by ALK2 knockdown.	Tacrolimus	0-5	activin A receptor type 1	Homo sapiens	96-100	
33572801-7	2021	The 2.17 A structure of this ALK2-FKBP12.6 complex bound to the inhibitor dorsomorphin showed FKBP12.6 binding to the GS domain of ALK2 in a manner equivalent to the FKBP12 complex, with ALK2 residues Phe198 and Leu199 extending into the FK506-binding pocket of FKBP12.6.	Tacrolimus	238-243	activin A receptor type 1	Homo sapiens	29-33	
33572801-7	2021	The 2.17 A structure of this ALK2-FKBP12.6 complex bound to the inhibitor dorsomorphin showed FKBP12.6 binding to the GS domain of ALK2 in a manner equivalent to the FKBP12 complex, with ALK2 residues Phe198 and Leu199 extending into the FK506-binding pocket of FKBP12.6.	Tacrolimus	238-243	activin A receptor type 1	Homo sapiens	131-135	
33572801-7	2021	The 2.17 A structure of this ALK2-FKBP12.6 complex bound to the inhibitor dorsomorphin showed FKBP12.6 binding to the GS domain of ALK2 in a manner equivalent to the FKBP12 complex, with ALK2 residues Phe198 and Leu199 extending into the FK506-binding pocket of FKBP12.6.	Tacrolimus	238-243	activin A receptor type 1	Homo sapiens	131-135